Search Results

Search Results for""
antleron
We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices.
Read More
logo-biolife
BIOLIFE4D is a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant – lifesaving technology that gives patients the gift of time.
Read More
bvh-logo-512-3
AstraZeneca established the BioVentureHub in 2014 as an open innovation ecosystem to further strengthen competitiveness and dynamism in the Scandinavian life science industry. Based on an innovative public-private partnership model and located at the heart of AstraZeneca Gothenburg, the BioVenturehub gives emerging biotech/medtech companies and academic groups from Sweden and abroad a unique opportunity to co-locate with - and tap into - the power of AstraZeneca’s world-class scientists and state-of-the-art lab facilities and infrastructure, and with each other.
Read More
0b16db_f503aa4bb89549e8bf505276a6602d82~mv2_d_2298_1480_s_2
SE3D.com is an EdTech startup, funded by the National Science Foundation, specializing in science education courseware and desktop 3D bioprinters for K9-14. Our unique curriculum and equipment is designed to prepare and propel the next generation of biomedical scientists, engineers and innovators.
Read More
Institute for Bioengineering of Catalonia (IBEC)
The Institute for Bioengineering of Catalonia (IBEC) conducts excellent interdisciplinary research at the frontiers of engineering and life sciences in order to generate new knowledge by putting together fields like nanomedicine, biophysics, biotechnology, tissue engineering and the applications of health information technology.
Read More
Medprin Biotech GmbH
MEDPRIN BIOTECH is a high-tech enterprise co-founded by outstanding biomedical scientists in September 2008, specialized in R & D, production and sales of regenerative medicine materials and regenerative implantable medical devices. MEDPRIN aims to become global leader in the field of implantable medical devices, relying on amazing capacity to provide excellent products for the patients worldwide based on biological 3D printing technology and nano-bionics technology, so MEDPRIN will accurately and efficiently manufacture more new implantable medical devices for human tissue recovery, replacement and regeneration, in accordance with the enterprise cultures featured in "innovation, cooperation and mutual love" and the quality policy to play a leading role in science & technology capacity and quality and constantly keep sound integrity to save more lives.
Read More
Lung Biotechnology PBC
Our vision is to discover the brilliant idea in search of realization. We advocate the new formulation, the inspired concept, and the big idea that might change our patients' lives. We ask ourselves "what if?" and "can you imagine?" And you know what? We can.
Read More
United Therapeutics Corporation
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. We have five approved products on the market today and are relentless in our pursuit of “medicines for life”®.UT is recognized as one of the Top 10 Corporate Citizens in the field of U.S. drug manufacturing
Read More
mayologo
Mayo Clinic's mission is to inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research. Our primary value is "The needs of the patient come first."
Read More
logo-ret
At OxSyBio, we are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications.
Read More
Tissue Regeneration Systems Inc
Tissue Regeneration Systems™ (TRS™) is a start-up medical device company commercializing a breakthrough skeletal reconstruction and bone regeneration technology platform licensed from the Universities of Michigan and Wisconsin. Our technology addresses a broad range of clinical applications, and has been validated by comprehensive University, NIH and company-sponsored research initiatives spanning a period of well over a decade.
Read More
3D Biotek, LLC
Founded in April 2007, 3D Biotek LLC is a biotechnology company located in New Jersey, USA. Using its Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Technology, 3D Biotek is a leader in the research and development of novel 3-dimensional (3D) cell culture devices for stem cell/tissue engineering and drug discovery applications.
Read More
North Carolina Biotechnology Center
The North Carolina Biotechnology Center accelerates life science technology-based economic development through innovation, commercialization, education, and business growth.NCBiotech is a private, non-profit corporation funded by the N.C. General Assembly. It is not a site for laboratory research; it works to support job creation in the life science industry.
Read More
FabRx Ltd.
FabRx is a specialist biotech company, focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices
Read More
amber
AMBER (Advanced Materials and BioEngineering Research) is a Science Foundation Ireland funded centre that provides a partnership between leading researchers in materials science and industry.
Read More
aprecia
Aprecia is a specialty pharmaceutical company that's committed to enhancing customers' experience with highly prescribed high-dose medications. Built upon our innovative and proprietary three-dimensional printing (3DP) technology platform, we focus on opportunities where there is a need for medicines that are easy to take.
Read More
Organovo1.jpg
Based in San Diego, CA, Organovo is the only public company that operates in the field of human tissue 3D printing. Its bioprinter has already achieved some breakthrough results in the printing of live liver tissue that responds to drug stimuli. Bioprinting organs such as liver, kidney and skin for transplants is one of the great promises of additive manufacturing methods and it is usually explored most at a academic level, without real commercial applications in sight for at least the next 5 years. However Organovo's technology is viewed as viable by the scientific community and holds great potential.
Read More
3dbio.png
Skolokovo Research Center resident company producing Russia's first bioprinter
Read More
aspect-biosystems.png
Aspect Biosystems is a Canadian biotechnology company founded in November, 2013. The company spun out from two internationally recognized research groups in engineering and medicine at the University of British Columbia. Aspect Biosystems is working towards a future where doctors determine which drugs work for their patients before prescribing them, where animals are no longer needed for the development of new therapeutics, and where lifesaving transplant organs are created, not harvested. To realise these goals, Aspect has developed a disruptive 3D bioprinting platform technology capable of creating living human tissues on demand.Our initial products aim to improve the predictive accuracy of the pre-clinical drug discovery process by providing the industry and researchers with the technology to create highly customized physiologically-relevant 3D human tissue models that they can employ in the development of new drugs. Aspect’s technology has the potential to drive a fundamental shift in the pharmaceutical industry, enabling the development of completely new therapeutics, and enabling pharma to test drugs they may have shelved in the past due to a lack of appropriate models. Furthermore, Aspect’s technology has the potential to significantly reduce the use of laboratory animals, supporting an industry wide mandate to reduce, refine and replace animal testing. Aspect has a long-term vision to expand beyond applications in drug development, by enabling Human Tissues on Demand™ for broad applications in the life sciences including regenerative medicine and organ transplantation.
Read More
n3D-biosciencesgo.png
Biomedical research is gravitating towards 3D cell culture models and tissue printing. At n3D, we sell kits and services for 3D cell culture. Our core technology is the magnetization of cells, which can then be directed using magnetic forces. In this manner, we can either levitate or bioprint cells. These cultures are faster to assemble than other systems and easier to handle with magnets without losing samples. Check out our products and our services for more information on our technology, and how we can help you!There is a growing push for biomedical and pharmaceutical research to transition towards three-dimensional (3D) cell culture models. Model selection is basically a choice between representation (animal testing) and throughput (in vitro cell culture). 3D cell culture brings the best of both worlds, but technical limitations in cost and handling have prevented its widespread use.To overcome these challenges, Nano3D Biosciences (n3D) has developed magnetic cell culture, where we magnetize cells using NanoShuttleTM-PL, and then rapidly print them into microtissues using magnetic force. This is an easy method for 3D cell culture that works with any cell type, making it ideal for biomedical research and high-throughput compound screening.We offer a wide product line for our technology with kits that are easy to use and fit seamlessly into existing cell culture workflows. We also provide services, in cell culture optimization or contract research, where we leverage our expertise in 3D cell culture to deliver quality results.At n3D, our goal is to develop our magnetic cell culture technology into the industry standard for 3D cell culture, with longer term focuses on personalized medicine and regenerative medicine.
Read More

This information will not be shared with third parties